Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals announced a joint venture with Hefei Tianhui Biotech to accelerate the development and commercialization of its oral insulin and other oral drug delivery technologies. The new company, OraTech Pharmaceuticals, will receive significant financial backing and leverage HTIT's manufacturing capabilities.

Related tickers: ORMP.

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. PepGen Inc. (NASDAQ: PEPG) On Jan. 8, PepGen said First Patient was dosed in CONNECT1-EDO51 Phase 2 clinical trial of PGN-EDO51 for duchenne muscular dystrophy patients amenable to Exon 51 skipping. The company’s stock ...

Related tickers: CALC, ORMP, FGEN, PEPG.